IGF-1 Treatment for Individuals With Short Stature Due to PAPP-A2 Deficiency

NCT02636270 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Short Stature

Interventions

DRUG: Increlex

Sponsor

Children's Hospital Medical Center, Cincinnati